Showing 15,081 - 15,100 results of 102,951 for search '(( a web decrease ) OR ( 5 ((point decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.72s Refine Results
  1. 15081
  2. 15082
  3. 15083

    Selective C−H Activation of Haloalkanes using a Rhodiumtrispyrazolylborate Complex by Andrew J. Vetter (2349535)

    Published 2009
    “…By comparing the kinetic stabilities of a series of 1-chloroalkane activation products (C<sub>1</sub>−C<sub>5</sub>), it was found that the chlorine substituent dramatically decreases reductive elimination rates as the substitution is closer to the metal center. …”
  4. 15084
  5. 15085

    E1784K accelerates a component of slow inactivation with 1-10s time constants. by Colin H. Peters (4430245)

    Published 2017
    “…<p><b>(A1 and A2)</b> Sample inward sodium currents recorded after 20ms to 60s repolarization pulses to -90mV following either a 500ms or 64s depolarization to -30mV. …”
  6. 15086
  7. 15087
  8. 15088

    Blood Pressure and LDL-C During Follow-up. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  9. 15089

    Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

    Published 2025
    “…The secondary endpoints were cardiovascular death, myocardial infarction, stroke, ischemic stroke, all-cause mortality, fracture, orthostatic hypotension, serious bleeding, and health-related quality of life. During a mean follow-up of 3.8 years, 31.7% (n = 64) of the patients in the intervention group and 37.5% (n = 72) in the control group reached the primary endpoint (HR 0.82, 95% CI 0.58–1.14, <i>P</i> = 0.23). …”
  10. 15090

    DataSheet_1_Human surfactant protein A inhibits SARS-CoV-2 infectivity and alleviates lung injury in a mouse infection model.pdf by Ikechukwu B. Jacob (18253300)

    Published 2024
    “…Pre-incubation of SARS-CoV-2 (Delta) with human SP-A inhibited virus binding and entry and reduced viral load in human lung epithelial cells, evidenced by the dose-dependent decrease in viral RNA, nucleocapsid protein (NP), and titer (p<0.01). …”
  11. 15091
  12. 15092
  13. 15093
  14. 15094
  15. 15095
  16. 15096

    Characterization of the direct Hox inputs shaping <i>tan</i> expression. by Eric M. Camino (451947)

    Published 2015
    “…<p>(A) The SM6 region of the t_MSE possesses five sites, S1-S5, with sequences characteristic of Abd-B (TTAT) and Abd-A (TAAT) binding sites. …”
  17. 15097
  18. 15098

    Targeted DNA demethylation in human cells by fusion of a plant 5-methylcytosine DNA glycosylase to a sequence-specific DNA binding domain by Jara Teresa Parrilla-Doblas (3825424)

    Published 2017
    “…In contrast, plants use specific DNA glycosylases that directly excise 5mC and initiate its substitution for unmethylated C in a base excision repair process. …”
  19. 15099
  20. 15100

    Image_5_Upregulated IL-6 Indicates a Poor COVID-19 Prognosis: A Call for Tocilizumab and Convalescent Plasma Treatment.TIF by Jian Wu (41301)

    Published 2021
    “…As a stable indicator, the changes in IL-6 levels could indicate the inflammatory conditions during a viral infection. …”